Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):168-176
Over the last decades there is an uncontrollable rise of MRSA prevalence. Infections caused by MRSA are associated with high mortality and healthcare costs. New antimicrobial drugs (anti-MRSA cephems, new glycopeptides, lipopeptides, glycilcyclines …